MotivaImplants® MotivaImagine® Careers

Investors

News

News

July 19, 2019
Establishment Labs certified as Carbon Neutral by the Government of Costa Rica
As a result of our core commitment to a sustainable environment, we are proud to announce that Establishment Labs’ global headquarters and manufacturing facilities in Costa Rica have been certified as Carbon Neutral by the Costa Rican Ministry of Environment, Energy, and Telecommunications (MINAE).
Read More
July 15, 2019
Establishment Labs Statement in Response to TGA’s Breast Implant Review related to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health in breast surgery. Women are at the center of everything we do at Establishment Labs and it is our mission to protect their health by offering safe solutions in breast aesthetics and
Read More
June 21, 2019
Expert Consensus Recommends Sixth Generation Motiva® Silicone Breast Implants
An international consensus of leading breast implant experts recently published in the Aesthetic Surgery Journal helps plastic surgeons better understand current surgical practices and establishes guidelines for surgeons transitioning to bioengineered smooth devices, such as the sixth-generation
Read More
June 16, 2019
Establishment Labs Holds Third Annual Motiva® Checkmate Women’s Professional Speed Chess Tournament
For the third year in a row, Establishment Labs is proud to sponsor the Motiva® Checkmate Tournament, an international women’s speed chess competition taking place in St. Petersburg, Russia on June 15-16, featuring 32 of the top ranked women’s professional chess players in the world, from 10
Read More
June 11, 2019
Establishment Labs Expands Team with Key Hires across Commercial, R&D and Operations
To support the ongoing growth of the Company, Establishment Labs is excited to announce the global appointments of Carole Chan as Executive Vice President of Commercial Operations; John Liljequist as Strategic Advisor focused on Asian Pacific markets; Ivan Bilic as Senior Sales Director in Europe;
Read More
June 6, 2019
Establishment Labs Announces Collaboration with Ipomia for Post-Op Bra Line
Establishment Labs Announces Collaboration with Ipomia for Post-Op Bra Line Establishment Labs, a global medical technology company focused on women’s health, has partnered with Ipomia, a pioneering post-op bra company, to create a line of bras exclusively for women who receive breast surgery with
Read More
June 6, 2019
Establishment Labs Participating at Key European Aesthetic Medicine Congress, Beauty through Science
Establishment Labs is participating in the Beauty through Science (BTS) International Aesthetic Medicine Congress in Stockholm, Sweden from June 5-8, 2019. One of the largest aesthetic medicine congresses in Northern Europe, BTS convenes over 1,000 academic experts, world-renowned surgeons and
Read More
June 5, 2019
Establishment Labs Expands Geographic Footprint: Launches Motiva Implants® in Thailand
Establishment Labs officially launched its Motiva SmoothSilk®/SilkSurface™ Round Implants and Motiva Ergonomix™ Implants last month in Thailand, one of the largest breast aesthetic markets in Asia, according to the International Society of Aesthetic Plastic Surgery .  At a special event held in
Read More
May 2, 2019
Establishment Labs to Participate in Sixth Annual International Breast Surgery Workshop
On May 4, 2019, Establishment Labs CEO and Founder Juan José Chacón-Quirós will participate in the Sixth Annual International Breast Surgery Workshop (IBSW) at the Ministry of Health in Rome, Italy.  Establishment Labs’ CEO will join a panel of distinguished companies, faculty and key opinion
Read More
April 17, 2019
Update to Our Valued Surgeons
In keeping with our open communication standard, I want to take this opportunity to communicate directly with you in light of some misleading information being circulated. As you may already know, an opinion piece on Establishment Labs was recently posted and reused by competitors, and is riddled with false information
Read More
Displaying 1 - 10 of 11